» Articles » PMID: 12656640

Drugs for Increasing Oxygen and Their Potential Use in Doping: a Review

Overview
Journal Sports Med
Specialty Orthopedics
Date 2003 Mar 27
PMID 12656640
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Blood oxygenation is a fundamental factor in optimising muscular activity. Enhancement of oxygen delivery to tissues is associated with a substantial improvement in athletic performance, particularly in endurance sports. Progress in medical research has led to the identification of new chemicals for the treatment of severe anaemia. Effective and promising molecules have been created and sometimes used for doping purposes. The aim of this review is to present methods, and drugs, known to be (or that might be) used by athletes to increase oxygen transport in an attempt to improve endurance capacity. These methods and drugs include: (i) blood transfusion; (ii) endogenous stimulation of red blood cell production at altitude, or using hypoxic rooms, erythropoietins (EPOs), EPO gene therapy or EPO mimetics; (iii) allosteric effectors of haemoglobin; and (iv) blood substitutes such as modified haemoglobin solutions and perfluorochemicals. Often, new chemicals are used before safety tests have been completed and athletes are taking great health risks. Such new chemicals have also created the need for new instrumental strategies in doping control laboratories, but not all of these chemicals are detectable. Further progress in analytical research is necessary.

Citing Articles

Advances in nanomaterials for treatment of hypoxic tumor.

Zou M, Liu W, Chen H, Bai X, Gao F, Ye J Natl Sci Rev. 2021; 8(2):nwaa160.

PMID: 34691571 PMC: 8288333. DOI: 10.1093/nsr/nwaa160.


Speed trends in male distance running.

Kruse T, Carter R, Rosedahl J, Joyner M PLoS One. 2014; 9(11):e112978.

PMID: 25409192 PMC: 4237511. DOI: 10.1371/journal.pone.0112978.


Hepcidin and sports anemia.

Kong W, Gao G, Chang Y Cell Biosci. 2014; 4:19.

PMID: 24731443 PMC: 4008387. DOI: 10.1186/2045-3701-4-19.


From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports?.

Fischetto G, Bermon S Sports Med. 2013; 43(10):965-77.

PMID: 23832852 DOI: 10.1007/s40279-013-0075-4.


Erythropoietin use and abuse.

John M, Jaison V, Jain K, Kakkar N, Jacob J Indian J Endocrinol Metab. 2012; 16(2):220-7.

PMID: 22470858 PMC: 3313739. DOI: 10.4103/2230-8210.93739.


References
1.
Sakas D, Whittaker K, CROWELL R, Zervas N . Perfluorocarbons: recent developments and implications for neurosurgery. J Neurosurg. 1996; 85(2):248-54. DOI: 10.3171/jns.1996.85.2.0248. View

2.
Bucci E, Razynska A, Kwansa H, OHearne M, Ulatowski J, Koehler R . Production and characteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acid. J Lab Clin Med. 1996; 128(2):146-53. DOI: 10.1016/s0022-2143(96)90006-2. View

3.
Kanstrup I, Ekblom B . Acute hypervolemia, cardiac performance, and aerobic power during exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982; 52(5):1186-91. DOI: 10.1152/jappl.1982.52.5.1186. View

4.
Piron M, Loo M, Gothot A, Tassin F, Fillet G, Beguin Y . Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood. 2001; 97(2):442-8. DOI: 10.1182/blood.v97.2.442. View

5.
Ashenden M, Gore C, Martin D, Dobson G, Hahn A . Effects of a 12-day "live high, train low" camp on reticulocyte production and haemoglobin mass in elite female road cyclists. Eur J Appl Physiol Occup Physiol. 1999; 80(5):472-8. DOI: 10.1007/s004210050620. View